Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saurav Misra
Observed names:
Dr. Saurav Misra,
Saurav misra
Institution:
Kalpana Chawla Government Medical College and Hospital
Observed institutions:
All India Institute of Medical Sciences Bhopal,
Kalpana Chawla Government Medical College and Hospital
ORCID:
0000-0003-2011-5895
Observed ORCID:
0000-0003-2011-5895
OpenAlex ID:
A5002472821
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
2024
·
Manmeet Kaur
, Saurav Misra
·
European Journal of Clinical Pharmacology
·
58
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
2024
·
Manmeet Kaur
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
18
Outpatient prescribing trends, rational use of medicine and impact of prescription audit with feedback at a tertiary care centre in India
2021
·
Shubham Atal
, Ratinder Jhaj
, et al.
·
The International Journal of Health Planning and Management
·
18
Teplizumab: type 1 diabetes mellitus preventable?
2023
·
Saurav Misra
, Ajay Kumar Shukla
·
European Journal of Clinical Pharmacology
·
13
Continued use of azithromycin for mild COVID-19 in India
2021
·
Shubham Atal
, Saurav Misra
, et al.
·
Journal of Family Medicine and Primary Care
·
11
Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer’s disease
2023
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
9
An overview of post COVID sequelae
2022
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
9
Antibody-dependent enhancement of virus infection and disease: implications in COVID-19
2022
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
9
A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study
2025
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Pharmacy And Bioallied Sciences
·
8
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic
2022
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
7
PDF
Clinical implications of anti-idiotype antibodies in COVID-19
2022
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
6
Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
2021
·
Dr. Ajay Kumar Shukla
, Dr. Saurav Misra
·
International Journal of Infectious Diseases
·
6
PDF
Seladelpar: a comprehensive review of its clinical efficacy and safety in the treatment of primary biliary cholangitis
2025
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
4
Pozelimab, a human monoclonal immunoglobulin for the treatment of CHAPLE disease
2024
·
Manmeet Kaur
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
4
Efficacy and safety of retatrutide for the treatment of obesity: a systematic review of clinical trials
2025
·
Saurav Misra
, Ravi Kant Narayan
, et al.
·
Journal of Basic and Clinical Physiology and Pharmacology
·
3
Safety Profile of Mass Administration of Albendazole Among School Children (6-19 Years): A Prospective Active Surveillance Study
2024
·
Babita Sheoran
, Tirthankar Deb
, et al.
·
Current Drug Safety
·
3
Safety monitoring of precautionary third dose of COVID-19 vaccines in a district in Northern India
2024
·
Tirthankar Deb
, Saurav Misra
, et al.
·
Journal of Family Medicine and Primary Care
·
2
Treatment Cost Along With Pattern of Disease and Therapy in the Intensive Care Unit of a Tertiary Care Teaching Hospital in India
2024
·
Shubham Atal
, Ahmad Najmi
, et al.
·
Cureus
·
2
PDF
The Use of Ivermectin in the Treatment of COVID-19
2023
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of General Internal Medicine
·
2
PDF
Trends in drug-induced liver injury (DILI): a case report-based analysis of clinical presentation, severity, preventability, seriousness, and outcomes over the last decade
2026
·
Saurav Misra
, Jayant Kumar Kairi
, et al.
·
Journal of Basic and Clinical Physiology and Pharmacology
·
1
WITHDRAWN: FDA Novel Approvals of Pharmaceuticals, 2013-2022: An Observational Study
2024
·
Saurav Misra
, Ajay Kumar Shukla
·
Applied Drug Research Clinical Trials and Regulatory Affairs
·
1
Deucravacitinib: moderate-to-severe plaque psoriasis preventable?
2024
·
Manmeet Kaur
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
1
A comprehensive review of Dual Orexin Receptor Antagonist (DORA), Daridorexant: Novel drug for sleep and related disorders
2024
·
Dr. Saurav Misra
, Dr. Manmeet Kaur
, et al.
·
International journal of life sciences, biotechnology and pharma research.
·
1
Adverse events following Covaxin administration among adolescents (15–18 years) – A pharmacovigilance study in a district in Northern India
2024
·
Tirthankar Deb
, Manmeet Kaur
, et al.
·
Journal of Family Medicine and Primary Care
·
1
Bispecific antibodies and its applications: a novel approach for targeting SARS-Cov-2
2023
·
Ajay Kumar Shukla
, Saurav Misra
·
Journal of Basic and Clinical Physiology and Pharmacology
·
1
Show more works
View as search
Works count:
34
Citation count:
199
H-index:
8
I10-index:
5
Year
Topic
Type
